ArticleVirology journal2023

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab.

Ivan Gentile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.